Cargando…
Transdermal Immunization with Microparticulate RSV-F Virus-like Particles Elicits Robust Immunity
No approved vaccines against respiratory syncytial virus (RSV) infections exist to date, due to challenges arising during vaccine development. There is an unmet need to explore novel approaches and a universal strategy to prevent RSV infections. Previous studies have proven the immune efficacy of vi...
Autores principales: | D’Sa, Sucheta, Braz Gomes, Kimberly, Allotey-Babington, Grace Lovia, Boyoglu, Cemil, Kang, Sang-Moo, D’Souza, Martin J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9030121/ https://www.ncbi.nlm.nih.gov/pubmed/35455333 http://dx.doi.org/10.3390/vaccines10040584 |
Ejemplares similares
-
Transdermal Vaccination with the Matrix-2 Protein Virus-like Particle (M2e VLP) Induces Immunity in Mice against Influenza A Virus
por: Braz Gomes, Kimberly, et al.
Publicado: (2021) -
Enhanced Immunogenicity of Adjuvanted Microparticulate HPV16 Vaccines Administered via the Transdermal Route
por: Vo, Trinh Phuong, et al.
Publicado: (2022) -
An Adjuvanted Inactivated SARS-CoV-2 Microparticulate Vaccine Delivered Using Microneedles Induces a Robust Immune Response in Vaccinated Mice
por: Vijayanand, Sharon, et al.
Publicado: (2023) -
Boosting In-Vivo Anti-Tumor Immunity with an Oral Microparticulate Breast Cancer Vaccine and Low-Dose Cyclophosphamide
por: Mulla, Nihal, et al.
Publicado: (2023) -
Complementary and Alternative Medicine Use for Primary Dysmenorrhea among Senior High School Students in the Western Region of Ghana
por: Samba Conney, Catherine, et al.
Publicado: (2019)